Second platinum therapy in patients with uterine cervical cancer previously treated with platinum chemotherapy

Cancer Chemotherapy and Pharmacology

Volumn 68, Issue 2, 2011, Pages 337-342

  Tanioka, Maki ^a,b   Katsumata, Noriyuki ^a   Yonemori, Kan ^a   Kouno, Tsutomu ^a   Shimizu, Chikako ^a   Tamura, Kenji ^a   Ando, Masashi ^a   Fujiwara, Yasuhiro ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b HYOGO CANCER CENTER   (Japan)

Author keywords

Cervical cancer; Platinum free interval; Predictive; Prognostic; Second line

Indexed keywords

CARBOPLATIN; CISPLATIN; IRINOTECAN; NEDAPLATIN; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CHEMORADIOTHERAPY; DRUG RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PLATINUM FREE INTERVAL; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR VOLUME; UTERINE CERVIX CANCER;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; TUMOR BURDEN; UTERINE CERVICAL NEOPLASMS;

EID: 79960915162     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/s00280-010-1494-7     Document Type: Article

References (13)

1. DM Parkin F Bray J Ferlay P Pisani 2005 Global cancer statistics, 2002 CA Cancer J Clin 55 74 108 15761078 10.3322/canjclin.55.2.74 (Pubitemid 40372904)
2. Berek JS, Neville Hacker F (2005) Practical gynecologic oncology. Lippincott Williams & Wilkins, New York
3. T Thigpen H Shingleton H Homesley L Lagasse J Blessing 1981 Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: a phase II study of the gynecologic oncology group Cancer 48 899 903 7196794 10.1002/1097-0142(19810815)48:4<899::AID-CNCR2820480406>3.0.CO;2-6 1:STN:280:DyaL38%2FgtFygtg%3D%3D (Pubitemid 11049085)
4. GR Weiss S Green EV Hannigan JG Boutselis EA Surwit DL Wallace DS Alberts 1990 A phase II trial of carboplatin for recurrent or metastatic squamous carcinoma of the uterine cervix: a southwest oncology group study Gynecol Oncol 39 332 336 2258080 10.1016/0090-8258(90)90262-J 1:STN:280:DyaK3M%2FnvVKrsg%3D%3D
5. J Arseneau JA Blessing FB Stehman R McGehee 1986 A phase II study of carboplatin in advanced squamous cell carcinoma of the cervix (a gynecologic oncology group study) Invest New Drugs 4 187 191 3525449 1:STN:280: DyaL283nslarsA%3D%3D (Pubitemid 16087374)
6. WP McGuire JA Blessing D Moore SS Lentz G Photopulos 1996 Paclitaxel has moderate activity in squamous cervix cancer. A gynecologic oncology group study J Clin Oncol 14 792 795 8622025 1:CAS:528:DyaK28Xit1Gjs7k%3D (Pubitemid 26085522)
7. CF Verschraegen T Levy AP Kudelka E Llerena K Ende RS Freedman CL Edwards M Hord M Steger AL Kaplan D Kieback A Fishman JJ Kavanagh 1997 Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervix J Clin Oncol 15 625 631 9053486 1:CAS:528:DyaK2sXhsVams78%3D (Pubitemid 27074231)
8. GP Sutton JA Blessing L Adcock KD Webster T DeEulis 1989 Phase II study of ifosfamide and mesna in patients with previously-treated carcinoma of the cervix. A gynecologic oncology group study Invest New Drugs 7 341 343 2513286 10.1007/BF00173765 1:STN:280:DyaK3c%2FptlOmsg%3D%3D (Pubitemid 19277482)
9. HJ Long III BN Bundy EC Grendys Jr JA Benda DS McMeekin J Sorosky DS Miller LA Eaton JV Fiorica 2005 Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a gynecologic oncology group study J Clin Oncol 23 4626 4633 15911865 10.1200/JCO.2005.10.021 1:CAS:528:DC%2BD2MXotFarsrk%3D (Pubitemid 46224065)
10. DH Moore JA Blessing RP McQuellon HT Thaler D Cella J Benda DS Miller G Olt S King JF Boggess TF Rocereto 2004 Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study J Clin Oncol 22 3113 3119 15284262 10.1200/JCO.2004.04.170 1:CAS:528:DC%2BD2cXpsVGrsrk%3D (Pubitemid 41103724)
11. BJ Monk MW Sill DS McMeekin DE Cohn LM Ramondetta CH Boardman J Benda D Cella 2009 Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic oncology group study J Clin Oncol 27 4649 4655 19720909 10.1200/JCO.2009.21.8909 1:CAS:528:DC%2BD1MXhtlGgtbnI
12. HJ Long III 2007 Management of metastatic cervical cancer: review of the literature J Clin Oncol 25 2966 2974 17617528 10.1200/JCO.2006.09.3781 1:CAS:528:DC%2BD2sXosFSgtbc%3D (Pubitemid 47123161)
13. PM Fracasso JA Blessing J Wolf TF Rocereto JS Berek S Waggoner 2003 Phase II evaluation of oxaliplatin in previously treated squamous cell carcinoma of the cervix: a gynecologic oncology group study Gynecol Oncol 90 177 180 12821360 10.1016/S0090-8258(03)00253-1 1:CAS:528:DC%2BD3sXkvVaqsLk%3D (Pubitemid 37338094)